Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 20, 2024 09:40 ET | Source: Nurix Therapeutics, Inc.

Nurix Presents the Discovery and Chemical Structure of First-in-Class CBL-B Inhibitor NX-1607 at the American Chemical Society (ACS) Meeting

Disclosure of the discovery and structure of NX-1607, the first inhibitor of CBL-B to advance into clinical studies.